[Federal Register Volume 62, Number 152 (Thursday, August 7, 1997)]
[Notices]
[Page 42587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20864]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the following National Heart, Lung, and Blood Institute Special
Emphasis Panel.
The meeting will be open to the public to provide concept review of
proposed contract or grant solicitations.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
inform the Contact Person listed below in advance of the meeting.
Name of Panel: Clinical Trials in Diabetes and CVD.
Date: September 19, 1997.
Time: 8:00 a.m.
Place: NIH Main Campus, 31 Center Drive, Building 31, 6th Floor,
C Wing, Conference Room 7.
Agenda: To consider the need for a clinical trial to determine
optimal intervention strategies to prevent or reduce CVD in diabetic
patients.
Contact Persons:
Peter Savage, M.D., Deputy Director, DECA, II Rockledge Center, 6701
Rockledge Drive, MSC 7938, Room 8104, Bethesda, Maryland 20892-7938,
(301) 435-0422.
George Sopko, M.D., Medical Officer, DHVD, II Rockledge Center, 6701
Rockledge Drive, MSC 7940, Room 9176, Bethesda, MD 20892-7940, (301)
435-0515.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart
and Vascular Diseases Research; 93.838, Lung Diseases Research; and
93.839, Blood Diseases and Resources Research, National Institutes
of Health.)
Dated: July 31, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-20864 Filed 8-6-97; 8:45 am]
BILLING CODE 4140-01-M
